Abstract

The zinc dithiocarbamates functionalized with folic acid 2Zn and 3Zn were synthesized with a simple straightforward method, using an appropriated folic acid derivative and a functionalized zinc dithiocarbamate (1Zn). Zinc complexes 2Zn and 3Zn show very low solubilities in water, making them useful for preparing Tc-99m radiopharmaceuticals with a potentially high molar activity. Thus, the transmetallation reaction in water medium between the zinc complexes 2Zn or 3Zn and the cation fac-[99mTc(H2O)3(CO)3]+, in the presence of the monodentate ligand TPPTS, leads to the formation of the 2 + 1 complexes fac-[99mTc(CO)3(SS)(P)] bioconjugated to folic acid (2Tc and 3Tc). In spite of the low solubility of 2Zn and 3Zn in water, the reaction yield is higher than 95%, and the excess zinc reagent is easily removed by centrifugation. The Tc-99m complexes were characterized by comparing their HPLC with those of the homologous rhenium complexes (2Re and 3Re) previously synthesized and characterized by standard methods. Preliminary in vivo studies with 2Tc and 3Tc indicate low specific binding to folate receptors. In summary, Tc-99m folates 2Tc and 3Tc were prepared in high yields, using a one-pot transmetallation reaction with low soluble zinc dithiocarbamates (>1 ppm), at moderate temperature, without needing a subsequent purification step.

Highlights

  • The bioconjugation of biomolecules to metallic fragments is an important topic with a wide range of potential applications, in particular, the development of new metal drugs for diagnosis and therapy [1,2,3]

  • We are developing a new approach based on a transmetallation reaction between zinc complexes and transition metal atoms [4,5,6]

  • The Zn(II) complexes are useful for this goal because it is well-known that the transmetallation reaction between Zn(II) and transition metals is usually favored from the thermodynamic point of view, due to the higher stability of bonds with a metal in dn configuration (n = 1–9) compared with those to a metal in a d10 configuration as Zn(II) [4,5,6,10]

Read more

Summary

Introduction

The bioconjugation of biomolecules to metallic fragments is an important topic with a wide range of potential applications, in particular, the development of new metal drugs for diagnosis and therapy [1,2,3] In this context, we are developing a new approach based on a transmetallation reaction between zinc complexes and transition metal atoms [4,5,6]. Our strategy is based on using a functionalized Zn(II) dithiocarbamate c (complex 1Zn, Figure 1) which contains succinimidyl ester groups that2mof a15ke poss conjugation to a wide range of biomolecules [4,5,6] This complex can be considere ful tool for the bioconjugation of transition metals because it can be conjugated to aecuuselefuslwtoiotlhfoar vtheerybiosicmonpjulgeaetixopneorfimtraennstitaiol nprmoectealdsubreeca. SScchheemme e1. 1S.ySnythnetshiseosfiszinocf czoimncplceoxems pbiloecxoensjubgiaotecdonwjiuthgfaotleicdawcidit(h2Zfnoalincda3cZind).(2Zn and 3Zn)

Rhenium Complexes
General
Synthesis of 2Zn
Synthesis of 3Zn
Synthesis of 2Re
Reverse-Phase High-Performance Liquid Chromatography
Determination of Solubilities of Zinc Compounds
Serum Stability Studies
3.12. Biodistribution Studies
Findings
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call